Comprehensive Study Notes on Phylum Apicomplexa and Genus Plasmodium

Characteristics of Phylum Apicomplexa

  • General Overview

    • Phylum Apicomplexa is a large and diverse group containing >5000> 5000 species.

    • Examples include: PlasmodiumPlasmodium spp., CryptosporidiumCryptosporidium, ToxoplasmaToxoplasma, BabesiaBabesia, TheileraTheilera, and EimeriaEimeria.

    • The majority are obligate intracellular parasites, with exceptions such as CryptosporidiumCryptosporidium and certain gregarines.

    • They are part of the Alveolata lineage.

  • Evolutionary Origin and the Apicoplast

    • They evolved from predatory flagellates/dinoflagellates.

    • They retained a chloroplast-like remnant known as the apicoplast.

    • The Apicoplast:

      • It is essential to the survival of the parasite.

      • It is implicated in host cell invasion and nutrient synthesis.

      • Hypothesized Mechanism: Origin via secondary endosymbiosis. An ancestral cell engulfed an algal cell. The algal cell lost its nucleus (leaving a diminished nucleus or DN) but the chloroplast remained. The algal cell became smaller, and the resulting chloroplast was surrounded by four membranes, becoming the apicoplast.

  • The Apical Complex

    • This characteristic structure is used for the attachment and invasion of host cells.

    • It is composed of five secretory/structural organelles:

      1. Polar ring: Electron-dense structures; function remains unknown.

      2. Conoid: Microtubules arranged in a spiral configuration.

      3. Rhoptries: Located at the anterior end; secretory in function. Involved in host cell invasion.

      4. Micronemes: Small elliptical vesicles that connect to rhoptries. Involved in host cell invasion.

      5. Subpellicular microtubule network: Provides structural support.

  • Reproduction and Life Cycle Phases

    • Replication results in the formation of invasive zoites.

    • Asexual replication: Involves numerous rounds of nuclear division without cytoplasmic division, resulting in multinucleated schizonts or meronts.

    • Internal Budding: In some species (e.g., Toxoplasma gondiiToxoplasma\,gondii, PlasmodiumPlasmodium), progeny are formed by internal budding into invasive stages.

    • Three Distinct Phases:

      1. Sporogony: Asexual phase immediately following the sexual phase (spore formation).

      2. Merogony: Asexual phase usually with multiple rounds of replication; results in invasive merozoites.

      3. Gametogony: The development of merozoites into gametes.

    • Spore Formation:

      • Many produce a resistant spore-like stage called oocysts (e.g., ToxoplasmaToxoplasma).

      • In vector-transmitted parasites (e.g., PlasmodiumPlasmodium), the spore wall is reduced or absent.

Introduction to Genus Plasmodium

  • Epidemiological Significance

    • Causative agent of malaria in humans and animals.

    • Evolutionary history: PlasmodiumPlasmodium species evolved long before vertebrates.

    • >200> 200 identified species infect birds, reptiles, rodents, and primates.

    • Transmission occurs via a mosquito vector (AnophelesAnopheles sp.).

    • Global Burden:

      • Endemic in 9090 countries.

      • >90%> 90\% of cases originate from Sub-Saharan Africa.

      • Other endemic regions: India, Brazil, Sri Lanka, Vietnam, Columbia, and the Solomon Islands.

      • 40%40\% of the world's population lives in endemic zones.

      • Annual prevalence: 300−500×106300-500 \times 10^6 people.

      • Annual death toll: approximately 500,000500,000.

  • Species Causing Human Malaria

    1. P.falciparumP. falciparum: The most deadly; prevalent in Sub-Saharan Africa, SE Asia, and South America.

    2. P.vivaxP. vivax: Historically the most common form; found in Africa, Asia, Mediterranean-bordering countries, and South America.

    3. P.malariaeP. malariae: Infects humans and chimps (reservoir hosts); found in Africa, Asia, Western Pacific, and South America; typically benign.

    4. P.ovalecurtisiP. ovale curtisi: Found in Sub-Saharan Africa, SE Asia, and Western Pacific.

    5. P.ovalewallikeriP. ovale wallikeri: Found in Sub-Saharan Africa, SE Asia, and Western Pacific.

    6. P.knowlesiP. knowlesi: Primarily a parasite of monkeys; causes serious infections in humans in SE Asia.

  • Historical Impact

    • Hippocrates provided the first clinical observations of symptoms.

    • Contributed to the fall of the Roman Empire.

    • Medieval crusaders fell victim to the disease.

    • Spanish conquistadors and slaves likely introduced it to the New World.

    • Malaria epidemics incapacitated Allied and Japanese forces during WWII and entire platoons during the Vietnam War.

The Plasmodium Life Cycle and Host Invasion

  • Main Stages

    1. Liver Stage (Exoerythrocytic Stage)

    2. Blood Stage (Erythrocytic Stage)

    3. Sexual Stage (Gametogony)

    4. Sporogony (In the mosquito)

  • Mechanism of Host Cell Invasion

    • Attachment: The apical end of the merozoite attaches to the host cell.

    • Protein Secretion: Rhoptries, micronemes, and dense granule proteins are expelled into the host cell cytoplasm.

    • Adhesion Proteins (Adhesins): Micronemal proteins belonging to the thrombospondin-related anonymous protein (TRAP) family, epidermal growth factor (EGF)-like, APPLE domains, and lectin domains are used.

    • Specific Recognition:

      • P.vivaxP. vivax: Uses Duffy binding protein to recognize the Duffy antigen (glycosylated protein) on the erythrocyte surface.

      • P.falciparumP. falciparum: Uses erythrocyte binding antigen (EBA)-175 to recognize sialic acid groups on the erythrocyte surface.

    • Entry: A subpellicular microtubule network of motor proteins (actin, myosin) facilitates motility and active invasion.

    • The Parasitophorous Vacuole (PV): As the parasite enters the RBC, tight junctions become annular and pull back over the parasite. A new membrane is formed = parasitophorous vacuole membrane (PVM), composed of parasite-derived lipids and/or host cell membrane. The PVM ruptures just prior to merozoite release.

  • Liver Stage Details

    • Sporozoites (from mosquito saliva) enter via the circulatory system (30 min30\,\text{min} window).

    • They pass through Kupffer cell macrophages (CD68CD68) in the liver sinusoids to reach hepatocytes.

    • Exoerythrocytic schizogony: Multiple rounds of division without cytokinesis, followed by budding.

    • Hypnozoites: In P.vivaxP. vivax and P.ovaleP. ovale, some sporozoites become dormant forms (hypnozoites) in the liver.

      • Relapse: Reactivation of hypnozoites (due to epigenetic control, subsequent infections like typhoid, or immunosuppression) causing the return of symptoms.

      • Recrudescence: Return of symptoms after merozoite quiescence (not hypnozoites), often due to ineffective immune response or incomplete drug treatment.

  • Blood Stage Details

    • Merozoites invade RBCs.

    • Ring stage: Early trophozoite.

    • Trophozoite: Ingests host hemoglobin (HbHb), producing diagnostic hemozoin (malarial pigment).

    • Synchronous erythrocytic schizogony: 3−53-5 rounds of nuclear replication and budding.

    • RBC Rupture: Releases parasite antigens, waste products, and pyrogens (fever-inducing chemicals), leading to malarial paroxysms.

    • Sequestration: P.falciparumP. falciparum-infected RBCs adhere to capillary endothelium of major organs.

  • Sexual Stage and Sporogony

    • Gametogony: Merozoites differentiate into microgametocytes (male) or macrogametocytes (female). These do not sequester.

    • In Mosquito Gut: Ingested gametocytes form microgametes and macrogametes. Flagellated microgametes fuse with macrogametes to form a zygote.

    • Ookinete: A motile stage that penetrates the insect gut wall.

    • Oocyst: Develops on the basal side of the gut epithelium; undergoes sporogony.

    • Sporozoites: Formed 10−2810-28 days post-infection; released into the hemocoel; invade salivary glands.

Behavioral and Chemical Ecology

  • Vector Manipulation

    • Infected mosquitoes probe hosts longer and bite more frequently.

    • Mosquitoes are preferentially drawn to infected persons.

    • HMBPP ((E)−4−hydroxy−3−methyl−but−2−enylpyrophosphate(E)-4-hydroxy-3-methyl-but-2-enylpyrophosphate): Produced by the apicoplast via the isoprenoid precursor pathway.

    • HMBPP induces the release of aldehydes, monoterpenes, and other volatile chemicals from infected host RBCs, enhancing vector attraction and stimulating vector feeding.

Clinical Manifestations and Fever

  • Malarial Paroxysms

    1. Cold Stage (Rigor): Intense cold, vigorous shivering (15−60 min15-60\,\text{min}).

    2. Hot Stage: Fever, severe headache, fatigue, nausea, dizziness (2−6 h2-6\,\text{h}). Temperature can exceed 42∘C42^{\circ}C (107.6∘F107.6^{\circ}F).

    3. Sweating Stage: Profuse sweating, fever declines (2−4 h2-4\,\text{h}).

  • Mechanism of Fever

    • Phagocytosis of waste and hemozoin causes the release of endogenous pyrogens like Tumor Necrosis Factor (TNF−αTNF-\alpha) and prostaglandins.

    • Pyrogens bind to the hypothalamic thermoregulatory center.

    • Neuronal Shift: Reducing the activity of warm-sensitive neurons and increasing cold-sensitive neurons.

    • The brain perceives the body is too cool, increasing heat production (shivering) and conservation (vasoconstriction), elevating the thermoregulatory set point.

Pathogenesis of P.falciparumP. falciparum

  • General Pathophysiology

    • Severe malarial anemia: Caused by the destruction of parasitized and non-parasitized RBCs. Bilirubin formation exceeds excretion (jaundice). Host cannot recycle iron bound to hemozoin.

    • Sequestration: Parasitized erythrocytes express PfEMP1PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1) on surface "knobs."

    • Host Receptors for Sequestration:

      • CD36CD36: Endothelial lining (binds CIDRCIDR domain).

      • ICAM−1ICAM-1: Brain vessels (binds DBL−βDBL-\beta domain).

      • CSACSA (Chondroitin Sulfate A): Placenta vessels (binds DBL−γDBL-\gamma domain).

      • CD31CD31: Endothelial junctions.

      • VCAM, ELAM1, Thrombospondin.

    • Rosetting: Infected RBCs bind to uninfected RBCs, clumping and clogging vessels (leads to ischemia, gangrene, edema).

  • Immune Evasion and Antigenic Variation

    • PfEMP1 Variants: Belong to the varvar gene family (~6060 genes). High genetic recombination allows millions of variants.

    • Antigenic Variation: Parasite switches surface variants at >2%> 2\% per generation to stay ahead of the host immune system.

    • Allelic Exclusion: Only a single varvar gene is expressed at any one time.

  • Cerebral Malaria

    • Characterized by convulsions, psychosis, unrousable coma.

    • Mechanism A (Sequestration): Obstructed flow, ischemia, hypoxia, and local high glycolysis leading to lactic acidosis and hypoglycemia.

    • Mechanism B (Cytokines): TNF−αTNF-\alpha upregulates Nitric Oxide (NO), causing vasodilation (intracranial hypertension) and aberrant neurotransmission.

  • Renal Failure and Black Water Fever

    • Black water fever: Severe fever, jaundice, vomiting, and hemoglobinuria (black urine) due to massive RBC rupture.

    • Renal Failure: Acute tubular necrosis from impaired blood flow and metabolic breakdown products.

    • Oliguria: <400 ml< 400\,\text{ml} urine in 24 h24\,\text{h}.

  • Modifications of the Host Erythrocyte

    • PTEX (Plasmodium Translocon of Exported proteins): A gatekeeper on the PV membrane that exports >10%> 10\% of parasite proteins into the host cell.

    • Maurer’s clefts: Membrane-bound compartments for protein trafficking.

    • Knobs: Formed by KAHRP (Knob-associated histidine-rich protein) and PfEMP2PfEMP2. They reorganize the sub-membrane cytoskeleton.

Comparison of Disease Severity (Untreated)

  • Severity of Initial Paroxysms

    • P.falciparumP. falciparum: Severe.

    • P.vivaxP. vivax: Moderate to severe.

    • P.ovaleP. ovale: Mild.

    • P.malariaeP. malariae: Mild to moderate.

  • Parasitemia (per mm3mm^3)

    • P.falciparumP. falciparum: Avg: 50,000−500,00050,000-500,000; Max: 2,500,0002,500,000.

    • P.vivaxP. vivax: Avg: 20,00020,000; Max: 50,00050,000.

    • P.ovaleP. ovale: Avg: 9,0009,000; Max: 30,00030,000.

    • P.malariaeP. malariae: Avg: 6,0006,000; Max: 20,00020,000.

  • Maximum Infection Duration

    • P.malariaeP. malariae: 20−50+20-50+ years.

    • P.vivaxP. vivax: 5−85-8 years (includes relapses).

    • P.falciparumP. falciparum: 6−176-17 months.

    • P.ovaleP. ovale: 12−2012-20 months.

Immunity and Resistance

  • Premunition

    • A pre-existing infection offers protection against newly arriving conspecifics and reduces severity.

    • Required to maintain immunity via repeated and regular exposure.

    • Older individuals exhibit lower parasitemia and fewer complications.

  • Genetic Resistance

    • Sickle Cell Allele: Offers protection against P.falciparumP. falciparum; correlation between allele prevalence and malaria endemicity.

    • G6PD (Glucose-6-phosphate dehydrogenase): Variants confer some protection.

    • Duffy Negative: West Africans lacking Duffy antigens are resistant to P.vivaxP. vivax.

Epidemiology, Control, and Treatment

  • Chemotherapy and Resistance

    • Chloroquine (CQ): Blocks heme dimerization. Heme is toxic; the parasite normally converts it to non-toxic hemozoin. If blocked, toxic heme causes cell lysis.

    • PfCRTPfCRT (P. falciparum Chloroquine Resistance Transporter): Resistant strains express an altered transporter that exports CQ from the food vacuole.

    • Drug Classes:

      • Fast-acting blood schizontocides: Chloroquine, Quinine, Mefloquine, Artemisinin derivatives.

      • Slow-acting: Doxycycline.

      • Tissue schizontocides (Anti-relapsing): Primaquine, Tafenoquine.

      • Combination Therapies: Fansidar®Fansidar^{\text{\textregistered}} (Pyrimethamine + Sulfadoxine), Malarone®Malarone^{\text{\textregistered}} (Atovaquone + Proguanil), Artemisinin combination treatment (ACT).

  • Vaccines and Control

    • Mosquirix (RTS, S/AS01): First malaria vaccine approved by WHO (Dec 2021). Developed by PATH and GSK. Recombinant vaccine directed against the sporozoite protein.

    • Vector Control: Genetically-modified mosquitoes, GambusiaGambusia (mosquito-eating fish), DDTDDT treatment of habitats, and insecticide-treated sleeping nets.

Questions & Discussion

  • Question: Why do PlasmodiumPlasmodium species occurring in temperate zones tend to have a longer hypnozoite stage than those in tropical zones?

  • Discussion: The transcript highlights that reactivation of the hypnozoite is under epigenetic control. In temperate zones, a longer dormant stage likely synchronizes the return of the parasite to the bloodstream with the seasonal emergence of the mosquito vector during warmer months, ensuring transmission continues.